MADOPAR Side Effects

5502581-3 | Completed Suicide
on Oct 26, 2007 Male patient from ITALY , 70 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Madopar (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Madopar dosage: 1025 Mg/day. During the same period patient was treated with APOMORPHINE HYDROCHLORIDE (28.8 Mg/day) (View Apomorphine Hydrochloride Review and Apomorphine Hydrochloride Label ), LEXOTAN (2.5 Mg/ml/d) (View Lexotan Review and Lexotan Label ), COMTAN (1400 Mg/day) (View Comtan Review and Comtan Label ).

5497033-3 | Completed Suicide
Patient was taking Madopar (View Usage). Patient had the following side effects: completed suicide on Oct 22, 2007 from ITALY Additional patient health information: Male patient , 70 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Madopar dosage: 1025 Mg/day. During the same period patient was treated with APOMORPHINE HYDROCHLORIDE (28.8 Mg/day) (View Apomorphine Hydrochloride Review and Apomorphine Hydrochloride Label ), LEXOTAN (View Lexotan Review and Lexotan Label ), COMTAN (1400 Mg/day) (View Comtan Review and Comtan Label ).

5486282-6 | Completed Suicide
Adverse event was reported on Oct 11, 2007 by a Male patient taking Madopar (View Usage) (Dosage: 1025 Mg/day) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: ITALY , 70 years of age, After Madopar was administered, patient had the following side effects: completed suicide. During the same period patient was treated with APOMORPHINE HYDROCHLORIDE (28.8 Mg/day) (View Apomorphine Hydrochloride Review and Apomorphine Hydrochloride Label ), LEXOTAN (View Lexotan Review and Lexotan Label ), COMTAN (1400 Mg/day) (View Comtan Review and Comtan Label ).

5122956-4 | Alanine Aminotransferase Increased, Anorexia, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Leukopenia, Liver Disorder
on Sep 13, 2006 Female patient from JAPAN , 82 years of age, weighting 85.98 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Madopar (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, leukopenia, liver disorder. Madopar dosage: . During the same period patient was treated with CALCIUM ASPARTATE (Trade Name Reported As 'astos-ca') (View Calcium Aspartate Review and Calcium Aspartate Label ), CIBENOL (View Cibenol Review and Cibenol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), FRANDOL (Dose Form Reported As Tape) (View Frandol Review and Frandol Label ). Patient was hospitalized.


4959180-1 | Diarrhoea
on Mar 17, 2006 Female patient from ARGENTINA , 88 years of age, was diagnosed with gastrointestinal disorder and was treated with Madopar (View Usage). Patient had the following side effects: diarrhoea. Madopar dosage: . During the same period patient was treated with SIFROL (View Sifrol Review and Sifrol Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ZELMAC / HTF 919A (View Zelmac / Htf 919a Review and Zelmac / Htf 919a Label ). Patient was hospitalized.

4955391-X | Diarrhoea
Patient was taking Madopar (View Usage). After Madopar was administered, patient had the following side effects: diarrhoea on Mar 17, 2006 from ARGENTINA Additional patient health information: Female patient , 88 years of age, was diagnosed with gastrointestinal disorder and. Madopar dosage: . During the same period patient was treated with SIFROL (View Sifrol Review and Sifrol Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ZELMAC / HTF 919A (View Zelmac / Htf 919a Review and Zelmac / Htf 919a Label ). Patient was hospitalized.

4587013-4 | Blood Pressure Increased, Dizziness, Fatigue, Headache, Nausea
Adverse event was reported on Sep 02, 2004 by a Female patient taking Madopar (View Usage) (Dosage: 150 Mg/d) was diagnosed with restless legs syndrome, headache (What is headache?), hypertension and. Location: , 77 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: blood pressure increased, dizziness (What is dizziness?), fatigue, headache (What is headache?), nausea (What is nausea?). During the same period patient was treated with TOREM (View Torem Review and Torem Label ), TOMAPYRIN C (0.5 Tablets/d) (View Tomapyrin C Review and Tomapyrin C Label ), BRISERIN N (1 Df, Once/single) (View Briserin-n Review and Briserin-n Label ).